Antibacterial agent 343
Antibacterial agent 343 (Compound 47) is an Antibacterial agent. Antibacterial agent 343 binds to the allosteric site of PBP2a to open its active site. Antibacterial agent 343 disrupts bacterial cell membranes, leading to protein leakage. Antibacterial agent 343 interacts with DNA and inhibits replication and transcription. Antibacterial agent 343 induces ROS accumulation. Antibacterial agent 343 exhibits antibacterial activity against MRSA, Staphylococcus aureus, and Enterococcus faecalis. Antibacterial agent 343 can be used for the research of methicillin-resistant Staphylococcus aureus infections.
For research use only. We do not sell to patients.
- Formula: C33H34N8O9S2
- Molecular Weight:750.80
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vitro
Antibacterial agent 343 exhibits antibacterial activity and potently inhibits MRSA, with an MIC50 of 0.5 μg/mL[1].
Antibacterial agent 343 (5-40 μg/mL; 24 h) exhibits low cytotoxicity against normal LO2 and BEAS-2B cells, with no significant reduction in cell viability observed even at concentrations up to 40 μg/mL after 24 h of treatment[1].
Antibacterial agent 343 (0.25-1 μg/mL; 0-14 h) inhibits the growth of MRSA in a concentration-dependent manner[1].
Antibacterial agent 343 (0.5-4 μg/mL) promotes concentration-dependent reactive oxygen species (ROS) accumulation in MRSA, and the ROS level increases to 2.5 times that of the control group at 1× MIC, thereby inducing oxidative stress[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LO2 normal human liver cells, BEAS-2B normal human bronchial epithelial cells
-
Concentration:5-40 μg/mL
-
Incubation Time:24 h
-
Result:Did not cause any significant reduction in cell viability in either LO2 or BEAS-2B cell lines at all tested concentrations.
Chemical Information
-
Molecular Weight 750.80
-
Formula C33H34N8O9S2
-
SMILES
NC1=NC(/C(C(NC2C(N3C2SCC(CN4CCN(C5=CC=C6C7=C5C=CC=C7C(N(C(CO)CO)C6=O)=O)CC4)=C3C(O)=O)=O)=O)=N/OC)=CS1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antibacterial agent 343
- Antibacterial agent343
- Antibacterial agent-343
- Bacterial
- DNA/RNA Synthesis
- DNA Alkylator/Crosslinker
- Reactive Oxygen Species (ROS)
- Penicillin-binding protein (PBP)
- MRSA
- human RBC
- reactive oxygen species
- bacterial cell membranes
- methicillin-resistant staphylococcus aureus infection
- PBP2a
- BEAS-2B
- calf thymus DNA
- biofilm
- LO2
- Inhibitor
- inhibitor
- inhibit